Temozolomide or Dacarbazine-based Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Endostatin (Primary) ; Temozolomide (Primary) ; Dacarbazine; Fluorouracil
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 12 Apr 2017 Status changed from recruiting to completed.
- 05 Jan 2016 Primary end point has been revised.(Progression free survival to overall response rate) as reported by ClinicalTrials.gov record.
- 05 Jan 2016 Planned number of patients changed from 10 to 16 as reported by ClinicalTrials.gov record.